Tag Archives: Pfizer

Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst

Confronting generic pricing pressure that put a hard cap on profits, Pfizer’s Upjohn spinoff deal with Mylan allowed both companies to reinvent themselves in the face of stagnant growth. The Pfizer left over after the merger could be a “messy” one, one analyst says, but brighter days should be on the horizon. After shedding its generics business,… Read More »

Top vaccine makers Merck and Pfizer target China and older adults next

During the past few decades, the number of companies producing vaccines has dwindled to just a handful. There are other players in the space, but today, the four big drug companies that now dominate the market are Merck, Pfizer, Sanofi Pasteur and GlaxoSmithKline. Selling a vaccine like Shingrix for the shingles or Gardasil 9 for… Read More »

Pfizer, Merck KGaA's Bavencio takes a hit with second ovarian cancer failure

Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And now the companies can make it two. Friday, the partners said they’d scrapped a phase 3 study examining Bavencio in combination with and/or after chemo in previously untreated patients after the drug showed it couldn’t… Read More »

Pfizer, GSK create consumer health powerhouse

Pharmaceutical giants Pfizer and GlaxoSmithKline are combining their over-the-counter drugs and healthcare products to create a new joint venture. The drugs include well-known brands, such as the painkillers Advil and Excedrin, Sensodyne toothpaste, Tums, and the vitamin brands Centrum and Caltrate. The companies plan to finalize the deal in the second half of 2019, and… Read More »